- Home
- RMBI vs RAPT Comparison
RMBI vs RAPT Comparison
Compare RMBI & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- RAPT
- Stock Information
- Founded
- RMBI 1887
- RAPT 2015
- Country
- RMBI United States
- RAPT United States
- Employees
- RMBI N/A
- RAPT N/A
- Industry
- RMBI Major Banks
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- RMBI Finance
- RAPT Health Care
- Exchange
- RMBI Nasdaq
- RAPT Nasdaq
- Market Cap
- RMBI 140.8M
- RAPT 117.5M
- IPO Year
- RMBI 2019
- RAPT 2019
- Fundamental
- Price
- RMBI $13.55
- RAPT $9.23
- Analyst Decision
- RMBI
- RAPT Buy
- Analyst Count
- RMBI 0
- RAPT 5
- Target Price
- RMBI N/A
- RAPT $42.00
- AVG Volume (30 Days)
- RMBI 55.3K
- RAPT 81.8K
- Earning Date
- RMBI 07-24-2025
- RAPT 08-07-2025
- Dividend Yield
- RMBI 4.54%
- RAPT N/A
- EPS Growth
- RMBI 2.54
- RAPT N/A
- EPS
- RMBI 0.89
- RAPT N/A
- Revenue
- RMBI $42,825,687.00
- RAPT N/A
- Revenue This Year
- RMBI N/A
- RAPT N/A
- Revenue Next Year
- RMBI N/A
- RAPT N/A
- P/E Ratio
- RMBI $14.91
- RAPT N/A
- Revenue Growth
- RMBI 2.64
- RAPT N/A
- 52 Week Low
- RMBI $11.26
- RAPT $5.67
- 52 Week High
- RMBI $15.15
- RAPT $30.60
- Technical
- Relative Strength Index (RSI)
- RMBI 50.00
- RAPT 57.71
- Support Level
- RMBI $13.03
- RAPT $7.04
- Resistance Level
- RMBI $13.91
- RAPT $8.91
- Average True Range (ATR)
- RMBI 0.57
- RAPT 0.83
- MACD
- RMBI -0.00
- RAPT 0.04
- Stochastic Oscillator
- RMBI 54.26
- RAPT 72.08
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.